U.S., Aug. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07105332) titled 'Feasibility Trial of a Sub-conjunctival Insert' on Sept. 05, 2022.
Brief Summary: The purpose of this single-centre, open label prospective study is to investigate a novel ocular mini insert (OMI) for detection of blood glucose levels in human subjects. First, the optimal technical parameters for measurement are determined on healthy subjects. Secondly, performance measurements follow investigating relationship between OMI signal and blood glucose in diabetes patients during short sessions with oral glucose tolerace test.
Study Start Date: Dec., 2006
Study Type: INTERVENTIONAL
Condition:
Diabetes (DM)
Intervention:
DEVICE: OMI ...